CSF3 and Huntington disease: Granulocyte colony stimulating factor treatment attenuates ROS production in this model and also lessens the presynaptic dysfunction [5].In contrast, majority of NMJs resistant to structural changes in the mouse model of Huntington's disease display huge increases in both mEPP frequency and EPP amplitude [39].